Acuitas Therapeutics
✓ VerifiedLipid nanoparticle delivery for mRNA vaccines
📊
$9M
Annual Revenue
👥
60
Employees
📦
5
Products
72%
72%
Profile Completeness
📄 About Acuitas Therapeutics
Acuitas Therapeutics develops proprietary lipid nanoparticle (LNP) systems for mRNA and gene therapy delivery, licensing LNP technology to vaccine and gene therapy companies.
🛡️
High Quality
Products
Products
🌐
Global
Distribution
Distribution
💡
Innovative
Technology
Technology
👥
Customer
Focused
Focused
📦 Featured Products
View All Products →
No products currently listed for Acuitas Therapeutics.
📍 Location & Offices
View on MapHeadquarters
Acuitas Therapeutics
1090 West Georgia Street Suite 1200
Vancouver, Canada
Visit Website →
Vancouver, Canada
🗺️
Vancouver, Canada
📋 Request a Quote
Send your requirements directly to Acuitas Therapeutics. Response typically within 48 hours.
